Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01581086 · ClinicalTrials.gov registry record
Vascular Subphenotypes of Lung Disease in HIV & COPD
A clinical trial, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 30
- Enrollment target
NCT01581086: Completed study, sponsored by University of Pittsburgh.
NCT01581086 is a clinical trial that has completed, run by University of Pittsburgh. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01581086 has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This study is looking for high blood pressure in the lungs (Pulmonary artery hypertension PAH) in HIV and COPD patients.
Primary Outcome
establish a pulmonary hypertension cohort for translational investigations, to determine the utility of NT-proBNP as a biomarker of PAH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2012-01 |
| Est. Completion | 2017-01 |
What the finished NCT01581086 record still lists
NCT01581086 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01581086 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01581086 about?
NCT01581086 is a clinical study titled "Vascular Subphenotypes of Lung Disease in HIV & COPD". This study is looking for high blood pressure in the lungs (Pulmonary artery hypertension PAH) in HIV and COPD patients.
What is the current status of trial NCT01581086?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2012-01. Estimated completion is 2017-01.
Who is sponsoring clinical trial NCT01581086?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia